Browse by author
Lookup NU author(s): Professor Debra Bevitt, Emeritus Professor Geoffrey Toms, Professor Thomas Lennard, Professor Bruce Westley, Dr Brian Angus
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Assessment of oestrogen and progesterone receptors (ER and PgR) in breast cancer is widely used for the prediction of response to endocrine therapy and as a prognostic marker. Cytosolic assays have been replaced in many centres by immunochemical techniques, which have many advantages including applicability to small samples, simplicity, and cost-effectiveness. This study describes the generation and characterisation of two novel murine monoclonal antibodies recognizing ER and PgR, designated NCL-ER-6F11 and NCL- PGR respectively, which are effective in heat-treated formalin-fixed, paraffin-embedded tissue. The antibodies have been characterized by Western blotting and by immunohistochemistry on normal and pathological breast and other tissues. NCL-ER-6F11 has been shown to compare favourably with a currently available ER antibody. These antibodies may prove of value in the assessment of hormone receptor status in human breast cancer.
Author(s): Bevitt D, Milton I, Piggot N, Henry L, Carter M, Toms G, Lennard TWJ, Westley B, Angus B, Horne C
Publication type: Article
Publication status: Published
Journal: Journal of Pathology
Year: 1997
Volume: 183
Issue: 2
Pages: 228-232
Print publication date: 01/10/1997
ISSN (print): 0022-3417
ISSN (electronic): 1096-9896
URL: http://dx.doi.org/10.1002/(SICI)1096-9896(199710)183:2<228::AID-PATH895>3.0.CO;2-X
DOI: 10.1002/(SICI)1096-9896(199710)183:2<228::AID-PATH895>3.0.CO;2-X
PubMed id: 9390038
Altmetrics provided by Altmetric
